Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Vishay Launches TANTAMOUNT® Solid Tantalum Chip Capacitors

Published: Thursday, August 22, 2013
Last Updated: Thursday, August 22, 2013
Bookmark and Share
Reliable molded capacitors combine robust anode design with Weibull grading and Hi-Rel screening options.

Vishay Intertechnology, Inc. has introduced a new series of TANTAMOUNT® surface-mount solid tantalum molded chip capacitors designed to provide improved performance and reliability in a wide variety of non-life-support medical monitoring and diagnostic instruments for in-home and hospital use.

Featuring a robust anode design, the TM3 series is 100 % surge current tested (B, C, D, and E case sizes) and available with Weibull grading and Hi-Rel screening options.

Vishay manufactures the new TM3 series at its Dimona, Israel, manufacturing facility. In addition to being ISO9001-certified, the Dimona plant was recently certified to ISO13485 standards, which outline medical device regulatory requirements for quality management systems and facilitate the requirements needed for medical device regulatory compliance by the U.S. Food and Drug Administration.

The Vishay Sprague TM3 devices released are optimized for input capacitor filters on DC/DC converters, hot plugging surges on battery chargers, low-drop-out devices, and capacitor charge pumps.

Typical end products will include glucose meters, infusion pumps, nebulizers, and thermometers.

TM3 devices are offered in a molded package in five standard EIA-535BAAC case codes: A, B, C, D, and E. The capacitors provide a capacitance range from 1 µF to 220 µF over voltage ratings from 4 V to 20 V; capacitance tolerances of ± 10 % and ± 20 %; high ripple current carrying capability to 11 A; and an operating temperature range of -55 °C to +125 °C with voltage derating.

RoHS-compliant and halogen-free, the TM3 series is available with 100 % matte tin or tin/lead terminations. The devices are compatible with high-volume automatic pick-and-place equipment, and their dry packaging is compliant to the JEDEC-033 standard.

Samples and production quantities of the new TM3 series are available now, with lead times of 12 weeks for larger orders.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Hepatitis C Virus Testing Guidelines Miss Too Many Cases
Urban emergency departments a good place to enact universal screening for adults.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!